The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
Open accessAbstract
BACKGROUND: Experimental animal data show that protection against severe acute respiratory syndrome coronavirus (SARS-CoV) infection with human monoclonal antibodies (mAbs) is feasible. For an effective immune prophylaxis in humans, broad coverage of different strains of SARS-CoV and control of potential neutralization escape variants will be required. Combinations of virus-neutralizing, noncompeting mAbs may have these properties. METHODS AND FINDINGS: Human mAb CR3014 has been shown to completely prevent lung pathology and abolish pharyngeal shedding of SARS-CoV in infected ferrets. We generated in vitro SARS-CoV variants escaping neutralization by CR3014, which all had a single P462L mutation in the glycoprotein spike (S) of the escape virus. In vitro experiments confirmed that binding of CR3014 to a recombinant S fragment (amino acid residues 318-510) harboring this mutation was abolished. We therefore screened an antibody-phage library derived from blood of a convalescent SARS patient for antibodies complementary to CR3014. A novel mAb, CR3022, was identified that neutralized CR3014 escape viruses, did not compete with CR3014 for binding to recombinant S1 fragments, and bound to S1 fragments derived from the civet cat SARS-CoV-like strain SZ3. No escape variants could be generated with CR3022. The mixture of both mAbs showed neutralization of SARS-CoV in a synergistic fashion by recognizing different epitopes on the receptor-binding domain. Dose reduction indices of 4.5 and 20.5 were observed for CR3014 and CR3022, respectively, at 100% neutralization. Because enhancement of SARS-CoV infection by subneutralizing antibody concentrations is of concern, we show here that anti-SARS-CoV antibodies do not convert the abortive infection of primary human macrophages by SARS-CoV into a productive one. CONCLUSIONS: The combination of two noncompeting human mAbs CR3014 and CR3022 potentially controls immune escape and extends the breadth of protection. At the same time, synergy between CR3014 and CR3022 may allow for a lower total antibody dose to be administered for passive immune prophylaxis of SARS-CoV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Self-citationGuan, Y., Zheng, B. J., He, Y. Q., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S. W., Li, P. H., Zhang, L. J., Guan, Y. J., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,406
Self-citation(2013) · Pediatrics · doi:10.1542/peds.2013-2511 · Cited by 1,845
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y., Tsoi, H.-W., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K.-H., & Yuen, K.-Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,544
Severe acute respiratory syndrome
Peiris, J. S. M., Guan, Y., & Yuen, K. Y. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,139
Self-citationReceptor and viral determinants of SARS‐coronavirus adaptation to human ACE2
Li, W., Zhang, C., Sui, J., Kuhn, J. H., Moore, M. J., Luo, S., Wong, S., Huang, I., Xu, K., Vasilieva, N., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600640 · Cited by 988
Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China
The Chinese SARS Molecular Epidemiology Consortium (2004) · Science · doi:10.1126/science.1092002 · Cited by 775
Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human
Song, H.-D., Tu, C.-C., Zhang, G.-W., Wang, S.-Y., Zheng, K., Lei, L.-C., Chen, Q.-X., Gao, Y.-W., Zhou, H.-Q., Xiang, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409608102 · Cited by 701
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697 · cited 2×
“Neutralizing antibodies against SARS CoV generated through experimental vaccination or monoclonal antibody (mAb) technology have repeatedly been shown in passive transfer experiments to protect mice from infection by reduction of viral replication [11,17 20].”
Wong, S. K., Li, W., Moore, M. J., Choe, H., & Farzan, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300520200 · Cited by 694
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
Jeffers, S. A., Tusell, S. M., Gillim-Ross, L., Hemmila, E. M., Achenbach, J. E., Babcock, G. J., Thomas, W. D., Thackray, L. B., Young, M. D., Mason, R. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403812101 · Cited by 605
Cheung, C. Y., Poon, L. L. M., Ng, I. H. Y., Luk, W., Sia, S.-F., Wu, M. H. S., Chan, K.-H., Yuen, K.-Y., Gordon, S., Guan, Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7819-7826.2005 · Cited by 461
Self-citationBisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
Subbarao, K., McAuliffe, J., Vogel, L., Fahle, G., Fischer, S., Tatti, K., Packard, M., Shieh, W.-J., Zaki, S., & Murphy, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3572-3577.2004 · Cited by 406
Buchholz, U. J., Bukreyev, A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385
Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications
Takada, A., & Kawaoka, Y. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.405 · Cited by 332
Meissner, H. C., Long, S. S., & Committee on Infectious Diseases, A. C. O. F. A. N. (2003) · Pediatrics · doi:10.1542/peds.112.6.1447 · Cited by 324
Profile of Specific Antibodies to the SARS-Associated Coronavirus
Li, G., Chen, X., & Xu, A. (2003) · New England Journal of Medicine · doi:10.1056/nejm200307313490520 · Cited by 307
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
ter Meulen, J., Bakker, A. B., van den Brink, E. N., Weverling, G. J., Martina, B. E., Haagmans, B. L., Kuiken, T., de Kruif, J., Preiser, W., Spaan, W., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16506-9 · Cited by 265
Self-citationBukreyev, A., Lamirande, E. W., Buchholz, U. J., Vogel, L. N., Elkins, W. R., Claire, M. S., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16501-x · Cited by 256
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
Yang, Z.-Y., Werner, H. C., Kong, W.-P., Leung, K., Traggiai, E., Lanzavecchia, A., & Nabel, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409065102 · Cited by 253
He, Y., Lu, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 241
de Kruif, J., Boel, E., & Logtenberg, T. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0204 · Cited by 173
Self-citationBakker, A. B. H., Marissen, W. E., Kramer, R. A., Papaneri, A. B., Weldon, W. C., Niezgoda, M., Hanlon, C. A., Thijsse, S., Backus, H. H. J., de Kruif, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9062-9068.2005 · Cited by 166
Self-citationQu, X.-X., Hao, P., Song, X.-J., Jiang, S.-M., Liu, Y.-X., Wang, P.-G., Rao, X., Song, H.-D., Wang, S.-Y., Zuo, Y., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500662200 · Cited by 161
Zwick, M. B., Wang, M., Poignard, P., Stiegler, G., Katinger, H., Burton, D. R., & Parren, P. W. H. I. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12198-12208.2001 · Cited by 160
Sui, J., Li, W., Roberts, A., Matthews, L. J., Murakami, A., Vogel, L., Wong, S. K., Subbarao, K., Farzan, M., & Marasco, W. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.5900-5906.2005 · Cited by 159
van den Brink, E. N., ter Meulen, J., Cox, F., Jongeneelen, M. A. C., Thijsse, A., Throsby, M., Marissen, W. E., Rood, P. M. L., Bakker, A. B. H., Gelderblom, H. R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1635-1644.2005 · Cited by 159
Self-citationGreenough, T. C., Babcock, G. J., Roberts, A., Hernandez, H. J., Thomas, Jr., Coccia, J. A., Graziano, R. F., Srinivasan, M., Lowy, I., Finberg, R. W., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427242 · Cited by 158
Liang, G., Chen, Q., Xu, J., Liu, Y., Lim, W. W. L., Peiris, M. J. S., Anderson, L. J., Ruan, L., Li, H., Kan, B., et al. (2004) · Emerging infectious diseases · doi:10.3201/eid1010.040445 · Cited by 148
Treatment of severe acute respiratory syndrome with convalescent plasma.
Wong, V. W., Dai, D., Wu, A. K. L., & Sung, J. J. �. (2003) · PubMed · Cited by 142
Corapi, W. V., Olsen, C. W., & Scott, F. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6695-6705.1992 · Cited by 129
Poon, L. L. M., Chan, K. H., Wong, O. K., Cheung, T., Ng, I. H. Y., Zheng, B., Seto, W., Yuen, K., Guan, Y., & Peiris, M. J. S. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.023663 · Cited by 126
Self-citationThe economic impact of quarantine: SARS in Toronto as a case study
Gupta, A., Moyer, C. A., & Stern, D. T. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.08.006 · Cited by 120
Epidemiological and genetic analysis of severe acute respiratory syndrome
Donnelly, C. A., Fisher, M. C., Fraser, C., Ghani, A. C., Riley, S., Ferguson, N. M., & Anderson, R. M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01173-9 · Cited by 113
He, Y., Zhu, Q., Liu, S., Zhou, Y., Baoan, Y., Li, J., & Jiang, S. (2005) · Virology · doi:10.1016/j.virol.2005.01.034 · Cited by 102
Kramer, R. A., Marissen, W. E., Goudsmit, J., Visser, T., der Horst, M. C.-V., Bakker, A. Q., de Jong, M., Jongeneelen, M. A. C., Thijsse, S., Backus, H. H. J., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526134 · Cited by 97
Self-citationSARS-Associated Coronavirus Quasispecies in Individual Patients
Xu, D., Zhang, Z., & Wang, F.-S. (2004) · New England Journal of Medicine · doi:10.1056/nejmc032421 · Cited by 82
Wang, S., Chou, T.-H. W., Sakhatskyy, P. V., Huang, S., Lawrence, J. M., Cao, H., Huang, X., & Lu, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1906-1910.2005 · Cited by 80
Laal, S., Burda, S. T., Górny, M. K., Karwowska, S., Buchbinder, A., & Zolla‐Pazner, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.4001-4008.1994 · Cited by 78
Li, A., Katinger, H. W. D., Posner, M. R., Cavacini, L. A., Zolla‐Pazner, S., Górny, M. K., Sodroski, J., Chou, T., Baba, T. W., & Ruprecht, R. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3235-3240.1998 · Cited by 78
Ho, K. Y., Singh, K. S., Habib, A. G., Ong, B. K. C., Lim, T. K., Ooi, E. E., Sil, B. K., Ling, A., Bai, X. L., & Tambyah, P. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/381558 · Cited by 57
Krieger, N., Chen, J. T., Coull, B. A., & Selby, J. V. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020162 · Cited by 56
Treatment of severe acute respiratory syndrome with convalescent plasma.
Burnouf, T. P. R., & Radosevich, M. (2003) · PubMed · Cited by 47
Pavia, A. T., NIELSEN, L., ARMINGTON, L., Thurman, D. J., Tierney, E. F., & NICHOLS, C. R. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115601 · Cited by 43
Poon, L. L. M., Leung, C. S.-W., Chan, K. H., Yuen, K., Guan, Y., & Peiris, J. S. M. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20379 · Cited by 29
Self-citationZhang, Z., Xie, Y.-W., Hong, J., Zhang, X., Kwok, S. Y., Huang, X., Wong, S. W., Wong, B. L., & SARSIg Group (2005) · Transfusion · doi:10.1111/j.1537-2995.2005.00179.x · Cited by 27
Severe Acute Respiratory Syndrome: Developing a Research Response
Montagne, J. R. L., Simonsen, L., Taylor, R. J., & Turnbull, J. (2004) · The Journal of Infectious Diseases · doi:10.1086/382225 · Cited by 16
Cloning and Expression of FECV Spike Gene in Vaccinia Virus
Klepfer, S. R., Reed, A. P., Martinez, M., Bhogal, B. S., Jones, E. V., & Miller, T. J. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1899-0_38 · Cited by 9
Cited by
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
“Among coronaviruses, point mutations have been demonstrated to confer resistance to neutralizing antibodies in MERS-CoV (Tang et al., 2014) and SARS-CoV-1 (Sui et al., 2008; ter Meulen et al., 2006).”
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2349-y · Cited by 1,885
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · doi:10.1101/2020.04.07.023903 · Cited by 1,752
Metadata
- Authors
- ter Meulen, J., van den Brink, E. N., Poon, L. L. M., Marissen, W. E., Leung, C. S. W., Cox, F., Cheung, C. Y., Bakker, A. Q., Bogaards, J. A., van Deventer, E., Preiser, W., Doerr, H. W., Chow, V. T., de Kruif, J., Peiris, J. S. M., & Goudsmit, J.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2006-07-04
- Volume
- 3
- Issue
- 7
- Pages
- e237
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2161428851
- Cited by
- 612
- References
- 51
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.